Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Specificity of ribozyme designed for mutated DHFR mRNA
Hiroyuki Kobayashi
, Nuna Kim
, Marc Eric Halatsch
, Takao Ohnuma
Icahn School of Medicine at Mount Sinai
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Specificity of ribozyme designed for mutated DHFR mRNA'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ribozyme
100%
Methylenetetrahydrofolate Reductase (MTHFR)
100%
Codon
50%
MOLT-3
50%
Two-point
25%
Methotrexate
25%
Point mutation
25%
Human Leukemia Cells
25%
Efficiently Cleaved
25%
Dihydrofolate Reductase Gene
25%
Antifolate
25%
Trimetrexate
25%
Essential Enzymes
25%
RNA Substrates
25%
Biochemistry, Genetics and Molecular Biology
Ribozyme
100%
Dihydrofolate Reductase
100%
Messenger RNA
100%
Codon
40%
RNA
40%
Enzyme
20%
Wild Type
20%
Point Mutation
20%
Antifolate
20%
Trimetrexate
20%
Methotrexate
20%
Pharmacology, Toxicology and Pharmaceutical Science
Ribozyme
100%
Dihydrofolate Reductase
100%
Messenger RNA
100%
Base
20%
Methotrexate
20%
Acute Leukemia
20%
Folic Acid Antagonist
20%
Trimetrexate
20%